SCHEMBL26050798

SCHEMBL26050798

OC(O)c1ccc(Br)c(F)c1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12533352 0.79 P2RX7 (0.31) —
SCHEMBL26050842 0.76 CYP1A2 (0.46) —
SCHEMBL26051618 0.75 — —
SCHEMBL26050828 0.75 APLNR (0.32) —
SCHEMBL28796789 0.71 CYP3A4 (0.42) —
SCHEMBL23114168 0.71 HTT (0.39) —
SCHEMBL26050105 0.71 PDE2A (0.31) —
SCHEMBL18302314 0.71 PDE2A (0.31) —
SCHEMBL1003501 0.70 TNF (0.35) —
SCHEMBL31070219 0.70 CYP3A4 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3793994-B1 INHIBITING AGENTS FOR BRUTON'S TYROSINE KINASE BIOGEN MA INC (US) 2023-08-23 — — EP disclosed
Send feedback